|
1
|
Nakamura T, Nakatsu N, Yoshida Y, et al:
Identification of candidate genes determining chemosensitivity to
anti-cancer drugs of gastric cancer cell lines. Biol Pharm Bull.
32:1936–1939. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ji YB, Qu ZY and Zou X: Juglone-induced
apoptosis in human gastric cancer SGC-7901 cells via the
mitochondrial pathway. Exp Toxicol Pathol. 63:69–78. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jackson C, Cunningham D and Oliveira J:
Gastric cancer: ESMO clinical recommendations for diagnosis,
treatment and follow-up. Ann Oncol. 20(Suppl 4): 34–36. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang WF, Li J, Du LT, et al: Krüppel-like
factor 8 overexpression is correlated with angiogenesis and poor
prognosis in gastric cancer. World J Gastroenterol. 19:4309–4315.
2013.
|
|
5
|
Yamada Y, Boku N, Nishina T, et al: Impact
of excision repair cross-complementing gene 1 (ERCC1) on the
outcomes of patients with advanced gastric cancer: correlative
study in Japan Clinical Oncology Group Trial JCOG9912. Ann Oncol.
24:2560–2565. 2013. View Article : Google Scholar
|
|
6
|
Li X, Qi W, Yao R, Tang D and Liang J:
Overexpressed transcription factor FOXM1 is a potential diagnostic
and adverse prognostic factor in postoperational gastric cancer
patients. Clin Transl Oncol. Jul 20–2013.(Epub ahead of print).
|
|
7
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar
|
|
8
|
Neer EJ, Lok JM and Wolf LG: Purification
and properties of the inhibitory guanine nucleotide regulatory unit
of brain adenylate cyclase. J Biol Chem. 259:14222–14229.
1984.PubMed/NCBI
|
|
9
|
Gierschik P, Milligan G, Pines M, et al:
Use of specific antibodies to quantitate the guanine
nucleotide-binding protein Go in brain. Proc Natl Acad Sci U S A.
83:2258–2262. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Corre I, Baumann H and Hermouet S:
Regulation by Gi2 proteins of v-fms-induced proliferation and
transformation via Src-kinase and STAT3. Oncogene. 18:6335–6342.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fan X, Brass LF, Poncz M, Spitz F, Maire P
and Manning DR: The alpha subunits of Gz and Gi interact with the
eyes absent transcription cofactor Eya2, preventing its interaction
with the six class of homeodomain-containing proteins. J Biol Chem.
275:32129–32134. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Montminy M: Transcriptional regulation by
cyclic AMP. Annu Rev Biochem. 66:807–822. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kan Z, Jaiswal BS, Stinson J, et al:
Diverse somatic mutation patterns and pathway alterations in human
cancers. Nature. 466:869–873. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jia D, Wei L, Guo W, et al: Genome-wide
copy number analyses identified novel cancer genes in
hepatocellular carcinoma. Hepatology. 54:1227–1236. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Garcia-Marcos M, Ghosh P and Farquhar MG:
Molecular basis of a novel oncogenic mutation in GNAO1. Oncogene.
30:2691–2696. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
17
|
Wang XN and Liang H: Some problems in the
surgical treatment of gastric cancer. Chin J Cancer. 29:369–373.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nguyen DX, Bos PD and Massagué J:
Metastasis: from dissemination to organ-specific colonization. Nat
Rev Cancer. 9:274–284. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Freeman A, Morris LS, Mills AD, et al:
Minichromosome maintenance proteins as biological markers of
dysplasia and malignancy. Clin Cancer Res. 5:2121–2132.
1999.PubMed/NCBI
|
|
20
|
Tait SW and Green DR: Mitochondria and
cell death: outer membrane permeabilization and beyond. Nat Rev Mol
Cell Biol. 11:621–632. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bratton MR, Antoon JW, Duong BN, et al:
Gαo potentiates estrogen receptor α activity via the ERK signaling
pathway. J Endocrinol. 214:45–54. 2012.
|
|
22
|
Baines CP and Molkentin JD: STRESS
signaling pathways that modulate cardiac myocyte apoptosis. J Mol
Cell Cardiol. 38:47–62. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fan Y, Chen H, Qiao B, et al: Opposing
effects of ERK and p38 MAP kinases on HeLa cell apoptosis induced
by dipyrithione. Mol Cells. 23:30–38. 2007.PubMed/NCBI
|
|
24
|
Raman M, Chen W and Cobb MH: Differential
regulation and properties of MAPKs. Oncogene. 26:3100–3112. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Youle RJ and Strasser A: The BCL-2 protein
family: opposing activities that mediate cell death. Nat Rev Mol
Cell Biol. 9:47–59. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Balmanno K and Cook SJ: Tumour cell
survival signalling by the ERK1/2 pathway. Cell Death Differ.
16:368–377. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bean GR, Ganesan YT, Dong Y, et al: PUMA
and BIM are required for oncogene inactivation-induced apoptosis.
Sci Signal. 6:ra202013.PubMed/NCBI
|
